183 related articles for article (PubMed ID: 27856269)
1. Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial.
Santolaya ME; Alvarez AM; Acuña M; Avilés CL; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Zubieta M; Toso A; Bataszew A; Farfán MJ; de la Maza V; Vergara A; Valenzuela R; Torres JP
Clin Microbiol Infect; 2017 Mar; 23(3):173-178. PubMed ID: 27856269
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of withholding antimicrobial therapy in children with cancer, fever, and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial.
Torres JP; Ibañez C; Valenzuela R; Rivera S; De la Maza V; Villarroel M; Coria P; Contardo V; Álvarez AM; Zubieta CM; Gutierrez V; Ducasse K; Martínez D; Santolaya ME
Clin Microbiol Infect; 2024 Apr; ():. PubMed ID: 38648896
[TBL] [Abstract][Full Text] [Related]
3. Frequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropenia.
Torres JP; Labraña Y; Ibañez C; Kasaneva P; Farfán MJ; De la Maza V; Villarroel M; Vergara I; Piemonte P; Zubieta M; Salgado C; Tordecilla J; Topelberg S; O Ryan M; Santolaya ME
Pediatr Infect Dis J; 2012 Sep; 31(9):889-93. PubMed ID: 22565292
[TBL] [Abstract][Full Text] [Related]
4. Respiratory Viral Infections and Coinfections in Children With Cancer, Fever and Neutropenia: Clinical Outcome of Infections Caused by Different Respiratory Viruses.
Torres JP; De la Maza V; Kors L; Villarroel M; Piemonte P; Izquierdo G; Salgado C; Tordecilla J; Contardo V; Farfán MJ; Mejías A; Ramilo O; Santolaya ME
Pediatr Infect Dis J; 2016 Sep; 35(9):949-54. PubMed ID: 27518750
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial.
Santolaya ME; Alvarez AM; Acuña M; Avilés CL; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Zubieta M; Farfán M; de la Maza V; Vergara A; Valenzuela R; Torres JP
J Antimicrob Chemother; 2018 Oct; 73(10):2860-2866. PubMed ID: 30010931
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical outcome of respiratory viral infections among children with cancer and febrile neutropenia.
Meena JP; Brijwal M; Seth R; Gupta AK; Jethani J; Kapil A; Jat KR; Choudhary A; Kabra SK; Dwivedi SN; Dar L
Pediatr Hematol Oncol; 2019 Sep; 36(6):330-343. PubMed ID: 31512959
[No Abstract] [Full Text] [Related]
7. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
Stern A; Carrara E; Bitterman R; Yahav D; Leibovici L; Paul M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012184. PubMed ID: 30605229
[TBL] [Abstract][Full Text] [Related]
8. Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropenia.
Shinn K; Wetzel M; DeGroote NP; Keller F; Briones M; Felker J; Castellino S; Miller TP
Pediatr Blood Cancer; 2020 Nov; 67(11):e28570. PubMed ID: 32881268
[TBL] [Abstract][Full Text] [Related]
9. Effects of respiratory viruses on febrile neutropenia attacks in children.
Aldemir-Kocabaş B; Karbuz A; Pekpak E; Karahan ZC; Dolapçı İ; İnce E; Uysal Z; Yavuz G; Çiftçi E; İnce E
Turk J Pediatr; 2017; 59(5):511-519. PubMed ID: 29745111
[TBL] [Abstract][Full Text] [Related]
10. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
[TBL] [Abstract][Full Text] [Related]
11. Administration Time for the First Dose of Antimicrobials in Episodes of Fever and Neutropenia in Children With Cancer.
De la Maza V; Simian D; Castro M; Torres JP; Lucero Y; Sepúlveda F; Mazquiaran S; Salazar C; Segovia L; Santolaya ME
Pediatr Infect Dis J; 2015 Oct; 34(10):1069-73. PubMed ID: 26125587
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and microbiological profile of viridans group streptococci bacteremia in children with cancer and high-risk febrile neutropenia].
Cortés D; Maldonado ME; Rivacoba MC; Maza V; Valenzuela R; Payá E; Contardo V; Álvarez AM; Avilés CL; Becker A; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Viviani T; Zubieta M; Santolaya ME
Rev Chilena Infectol; 2020 Aug; 37(4):383-388. PubMed ID: 33399658
[TBL] [Abstract][Full Text] [Related]
13. Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia.
Thangthong J; Anugulruengkitt S; Lauhasurayotin S; Chiengthong K; Poparn H; Sosothikul D; Techavichit P
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3487-3492. PubMed ID: 33369443
[TBL] [Abstract][Full Text] [Related]
14. Frequent Respiratory Viral Infections in Children with Febrile Neutropenia - A Prospective Follow-Up Study.
Söderman M; Rhedin S; Tolfvenstam T; Rotzén-Östlund M; Albert J; Broliden K; Lindblom A
PLoS One; 2016; 11(6):e0157398. PubMed ID: 27309354
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of step-down to oral outpatient treatment versus inpatient antimicrobial treatment in pediatric cancer patients with febrile neutropenia: A noninferiority multicenter randomized clinical trial.
Avilés-Robles MJ; Reyes-López A; Otero-Mendoza FJ; Valencia-Garin AU; Peñaloza-González JG; Rosales-Uribe RE; Muñoz-Hernández O; Garduño-Espinosa J; Juárez-Villegas L; Zapata-Tarrés M
Pediatr Blood Cancer; 2020 Jun; 67(6):e28251. PubMed ID: 32196898
[TBL] [Abstract][Full Text] [Related]
16. Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.
Loeffen EA; Te Poele EM; Tissing WJ; Boezen HM; de Bont ES
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008382. PubMed ID: 26899263
[TBL] [Abstract][Full Text] [Related]
17. Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.
Rivas-Ruiz R; Villasis-Keever M; Miranda-Novales G; Castelán-Martínez OD; Rivas-Contreras S
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009031. PubMed ID: 30887505
[TBL] [Abstract][Full Text] [Related]
18. Etiology and clinical course of febrile neutropenia in children with cancer.
Hakim H; Flynn PM; Knapp KM; Srivastava DK; Gaur AH
J Pediatr Hematol Oncol; 2009 Sep; 31(9):623-9. PubMed ID: 19644403
[TBL] [Abstract][Full Text] [Related]
19. Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial.
Santolaya ME; Alvarez AM; Aviles CL; Becker A; King A; Mosso C; O'Ryan M; Paya E; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
Pediatr Infect Dis J; 2008 Jun; 27(6):538-43. PubMed ID: 18458649
[TBL] [Abstract][Full Text] [Related]
20. [Characterization of episodes of febrile neutropenia in children with acute myeloid leukemia and acute lymphoblastic leukemia].
Ducasse K; Fernández JP; Salgado C; Alvarez AM; Avilés CL; Becker A; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Santolaya ME
Rev Chilena Infectol; 2014 Jun; 31(3):333-8. PubMed ID: 25146209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
